The Role of Endovascular Stents in Dialysis Access Maintenance

Mohamad El Kassem1, Issam Alghamdi1, Roberto I Vazquez-Padron1

  • 1Interventional Nephrology Section, Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, FL; Vascular Surgery, Department of Surgery, University of Miami Miller School of Medicine, Miami, FL; Division of Nephrology, Albany Medical College, Albany, NY; Internal Medicine Hospitalist Division, South Miami Hospital, South Miami, FL.

Insights

Stents are increasingly used for hemodialysis vascular access dysfunction, but many uses are off-label. Evidence guides stent use, recommending against their use at cannulation sites and for dialysis access aneurysms.

Area of Science:

  • Nephrology
  • Interventional Radiology
  • Vascular Surgery

Background:

  • Vascular stenosis is a primary cause of hemodialysis vascular access dysfunction.
  • Percutaneous transluminal angioplasty is the standard treatment, but stent use is increasing.
  • Most stent applications in vascular access dysfunction are off-label, except for specific FDA-approved stent grafts.

Purpose of the Study:

  • To review the current evidence for stent use in various conditions causing hemodialysis vascular access dysfunction.
  • To evaluate the efficacy and limitations of stents in treating specific vascular access complications.
  • To provide evidence-based recommendations for stent utilization in hemodialysis access.

Main Methods:

  • Systematic review of published reports on stent use in hemodialysis vascular access dysfunction.
  • Analysis of evidence supporting stent application in conditions like venous graft anastomosis stenosis, cephalic arch stenosis, and central venous stenosis.
  • Evaluation of data regarding stent use in dialysis access aneurysms and device-induced stenosis.

Main Results:

  • Stents show potential in treating diverse conditions including graft stenosis, cephalic arch stenosis, and thrombosed grafts.
  • Specific contraindications exist, such as avoiding stents at cannulation sites and for aneurysm elimination.
  • Kidney Disease Outcomes Quality Initiative guidelines recommend limiting stent use to specific scenarios like elastic lesions and recurrent stenosis.

Conclusions:

  • Stent use in hemodialysis vascular access dysfunction is expanding, with varying levels of evidence.
  • Clear recommendations exist against using stents at cannulation sites and for dialysis access aneurysms.
  • Further research is necessary to solidify evidence for many stent applications in vascular access management.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
3.2K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.5K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.8K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
2.0K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
487
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.9K